Market Overview

Morning Market Losers

Related ADXS
Advaxis Provides Clinical Update For Phase 1/2 Trial Of ADXS-HPV Immunotherapy Product Candidate In Anal Cancer
Winners & Losers From Monday, August 25
Related CTHR
7 Stocks Mined From The Bottom Decile
Events for the Week of Aug. 25-29th

Advaxis (NASDAQ: ADXS) shares fell 24.32% to $3.08 after the company priced 4,080,000 shares of common stock at $3.00 per share.

Charles & Colvard (NASDAQ: CTHR) shares slipped 16.48% to $3.30 on Q4 results. Charles & Colvard reported its Q4 earnings of $0.01 per share on revenue of $8.61 million.

Document Security Systems (NYSE: DSS) shares tumbled 11.69% to $1.36 after the company reported Q4 results. Document Security posted a quarterly net loss of $0.8 million, or $0.02 per share.

Marchex (NASDAQ: MCHX) fell 7.54% to $10.30 after the company priced 5,714,000 shares of Class B common stock at $10.50 per share.

LiqTech International (NYSE: LIQT) shares dropped 7.22% to $1.90 after the company reported a fiscal 2013 net loss of $4,827,477.

Solazyme (NASDAQ: SZYM) shares dropped 6.02% to $10.85 after the company priced offering of $130 million of 5.00% Convertible Senior Subordinated Notes due 2019 and 5 million shares of at $11.00 per share.

Citigroup (NYSE: C) shares fell 4.90% to $47.70 after the company reported that its capital plan was not approved by the Federal Reserve. The Fed said that Citi's plan did not fix previously raised issues. Analysts at Keefe Bruyette & Woods downgraded Citigroup from Outperform to Market Perform and lowered the target price from $58 to $52.

Posted-In: market losersNews Movers & Shakers Intraday Update Markets


Related Articles (C + ADXS)

Around the Web, We're Loving...

Get Benzinga's Newsletters

Benzinga Professional